[go: up one dir, main page]

ZA964563B - Isoindole derivatives their preparation and their application in therapy - Google Patents

Isoindole derivatives their preparation and their application in therapy

Info

Publication number
ZA964563B
ZA964563B ZA964563A ZA964563A ZA964563B ZA 964563 B ZA964563 B ZA 964563B ZA 964563 A ZA964563 A ZA 964563A ZA 964563 A ZA964563 A ZA 964563A ZA 964563 B ZA964563 B ZA 964563B
Authority
ZA
South Africa
Prior art keywords
therapy
preparation
application
isoindole derivatives
isoindole
Prior art date
Application number
ZA964563A
Other languages
English (en)
Inventor
Samir Jegham
Philippe Burnier
Frederic Puech
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA964563(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr
Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA964563B publication Critical patent/ZA964563B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA964563A 1995-06-02 1996-06-03 Isoindole derivatives their preparation and their application in therapy ZA964563B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506563A FR2734820B1 (fr) 1995-06-02 1995-06-02 Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506564A FR2734821B1 (fr) 1995-06-02 1995-06-02 Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
ZA964563B true ZA964563B (en) 1996-12-12

Family

ID=26232004

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA964563A ZA964563B (en) 1995-06-02 1996-06-03 Isoindole derivatives their preparation and their application in therapy

Country Status (27)

Country Link
US (1) US5843975A (xx)
EP (1) EP0835254B1 (xx)
JP (1) JP3856829B2 (xx)
KR (1) KR100457502B1 (xx)
CN (1) CN1075072C (xx)
AR (1) AR006301A1 (xx)
AT (1) ATE184005T1 (xx)
AU (1) AU699367B2 (xx)
BR (1) BR9608896A (xx)
CA (1) CA2223011C (xx)
CO (1) CO4700462A1 (xx)
CZ (1) CZ378497A3 (xx)
DE (1) DE69604071T2 (xx)
DK (1) DK0835254T3 (xx)
ES (1) ES2138346T3 (xx)
GR (1) GR3031710T3 (xx)
HK (1) HK1014938A1 (xx)
HU (1) HU224879B1 (xx)
MX (1) MX9709410A (xx)
NO (1) NO309091B1 (xx)
NZ (1) NZ310487A (xx)
PL (1) PL183919B1 (xx)
RU (1) RU2164226C2 (xx)
SK (1) SK281934B6 (xx)
TW (1) TW360654B (xx)
WO (1) WO1996038444A1 (xx)
ZA (1) ZA964563B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
SK9562003A3 (en) * 2001-01-31 2004-04-06 Synaptic Pharma Corp Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
IL160744A0 (en) * 2001-09-26 2004-08-31 Pharmacia Italia Spa Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
JP2009525318A (ja) * 2006-02-01 2009-07-09 ファイザー・プロダクツ・インク 抗菌剤としてのベンズイソオキサゾールオキサゾリジノン
WO2008120655A1 (ja) * 2007-03-30 2008-10-09 Institute Of Medicinal Molecular Design, Inc. Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
EP2123159A1 (de) * 2008-05-21 2009-11-25 Bayer CropScience AG (1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
WO2011075565A1 (en) * 2009-12-18 2011-06-23 Janssen Pharmaceutica Nv SUBSTITUTED AMINOTHIAZOLONE INDAZOLES AS ESTROGEN RELATED RECEPTOR-Aα MODULATORS
MX2012009528A (es) * 2010-02-17 2013-01-14 Janssen Pharmaceutica Nv Aminotiazolonas como moduladores de receptores alfa relacionados con el estrógeno.
WO2016097355A1 (en) * 2014-12-19 2016-06-23 Ge Healthcare Limited Labelled oxazolidinone derivatives
DE102015012050A1 (de) * 2015-09-15 2017-03-16 Merck Patent Gmbh Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) * 2016-09-05 2017-12-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ) Иммунодепрессант

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
CA2079906A1 (en) * 1991-02-20 1992-08-21 Yusaku Koda Articulator

Also Published As

Publication number Publication date
DE69604071T2 (de) 2000-04-06
WO1996038444A1 (fr) 1996-12-05
TW360654B (en) 1999-06-11
DE69604071D1 (de) 1999-10-07
CA2223011A1 (en) 1996-12-05
ATE184005T1 (de) 1999-09-15
KR100457502B1 (ko) 2005-09-05
NZ310487A (en) 1999-05-28
RU2164226C2 (ru) 2001-03-20
HUP9901349A3 (en) 2000-02-28
HUP9901349A2 (hu) 1999-08-30
NO975530D0 (no) 1997-12-01
SK161497A3 (en) 1998-05-06
PL323673A1 (en) 1998-04-14
AU6128896A (en) 1996-12-18
CN1191534A (zh) 1998-08-26
CZ378497A3 (cs) 1998-04-15
SK281934B6 (sk) 2001-09-11
AU699367B2 (en) 1998-12-03
HK1014938A1 (en) 1999-10-08
GR3031710T3 (en) 2000-02-29
EP0835254A1 (fr) 1998-04-15
DK0835254T3 (da) 2000-03-27
CA2223011C (en) 2007-01-09
NO975530L (no) 1998-02-02
EP0835254B1 (fr) 1999-09-01
PL183919B1 (pl) 2002-08-30
KR19990022187A (ko) 1999-03-25
AR006301A1 (es) 1999-08-25
HU224879B1 (en) 2006-03-28
NO309091B1 (no) 2000-12-11
CO4700462A1 (es) 1998-12-29
BR9608896A (pt) 1999-06-29
JPH11507330A (ja) 1999-06-29
MX9709410A (es) 1998-07-31
ES2138346T3 (es) 2000-01-01
JP3856829B2 (ja) 2006-12-13
US5843975A (en) 1998-12-01
CN1075072C (zh) 2001-11-21

Similar Documents

Publication Publication Date Title
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
PL327610A1 (en) Quinoline and quinozoline compounds useful in therapy
IL122216A0 (en) Dolastatin derivatives their preparation and use
IL123600A0 (en) 2(1H)-Quinolone derivatives their preparation and their use in therapy
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
IL114795A0 (en) N-benzylindole- and benmzopyrazole derivatives their preparation and use
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
HUP9901908A3 (en) P16 expression constructs and their application in cancer therapy
IL118119A0 (en) Azacycloalkane derivatives their preparation and their application in therapy
ZA964563B (en) Isoindole derivatives their preparation and their application in therapy
AU7216996A (en) A paf-acetylhydrolase and use in therapy
AP9500727A0 (en) 13-substituted milbemy in derivatives their preparation and use
AP9300575A0 (en) Piperidine derivatives their preparation and their application in therapy
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
IL116712A0 (en) Substituted 2-phenylpyridines their preparation and use
IL101617A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their application in therapy
GB9413090D0 (en) Benzazepine derivatives compositions containing them and their use in therapy
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
IL123156A0 (en) Benzenesulphonamide derivatives their preparation and their application in therapy
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
IL116658A0 (en) Peptides their preparation and use
IL116711A0 (en) Substituted 2-phenylpyridines their preparation and use
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy